Nanocrystal Formulation to Enhance Oral Absorption of Silybin: Preparation, In Vitro Evaluations, and Pharmacokinetic Evaluations in Rats and Healthy Human Subjects
Pharmaceutics · 02.08.2024 · 16 (8) · 1033
DOI: 10.3390/pharmaceutics16081033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 02.08.2024. Verfasst von SeungRee Seo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Life Science Research Institute, Daewoong Pharmaceuticals, Yongin-si 17028, Republic of Korea. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF) grants funded by the Korean Government Ministry of Science and ICT (MSIT), Korean Government Ministry of Science and ICT.
Abstract (Originalsprache)
Despite the various therapeutic benefits and high tolerance of orally administered silybin, poor water-solubility can be the main restrictive physicochemical feature, which results in low oral bioavailability in the absorption. A milk thistle nanocrystal formulation (HM40) was prepared using a modified wet-milling method. Comprehensive characterization was performed to determine the physical morphology, crystallinity, and physicochemical properties. The long-term stability was evaluated over 24 months. In vitro silybin release was assessed at pH 1.2 for 2 h, followed by pH 6.8 for 4 h. Finally, in vivo pharmacokinetic studies were conducted in rats and healthy human volunteers. HM40 exhibited a nanocrystal structure maintaining crystallinity and enhanced the solubility and dissolution of silybin compared to that of the raw material. The stability over 24 months revealed consistent surface morphology, particle size, silybin content, and solubility. In vitro release profiles indicated a significant increase in the silybin release from HM40. In vivo pharmacokinetic studies demonstrated that HM40 showed 2.61- and 1.51-fold higher oral bioavailability in rats and humans, respectively, than that of the reference capsule. HM40 formulation presents a stable and promising approach for the oral delivery of poorly water-soluble silybin, with the potential for use in pharmaceutical formulations containing milk thistle.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Life Science Research Institute, Daewoong Pharmaceuticals, Yongin-si 17028, Republic of Korea.
- Bio-Synectics, Inc., Seoul 08826, Republic of Korea.
- College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea.
- Department of Biomedicine, Health & Life Convergence Sciences (BK21 Four) and Biomedical and Healthcare Research Institute, Mokpo National University, Jeonnam 58554, Republic of Korea.
- Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
- College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Jeonnam 58554, Republic of Korea.
ORCID-Profile: Dae-Duk Kim
Förderung
- National Research Foundation of Korea (NRF) grants funded by the Korean Government Ministry of Science and ICT (MSIT)
- Korean Government Ministry of Science and ICT
Zitieren
APA
Seo, S., Kim, G. Y., Kim, M. H., Lee, K. W., Kim, M. J., Chaudhary, M., Bikram, K., Kim, T., Choi, S., Yang, H., Park, J. W., Kim, D. D., & Kim, K. T. (2024). Nanocrystal Formulation to Enhance Oral Absorption of Silybin: Preparation, In Vitro Evaluations, and Pharmacokinetic Evaluations in Rats and Healthy Human Subjects. Pharmaceutics, 16(8), 1033. https://doi.org/10.3390/pharmaceutics16081033
Vancouver
Seo S, Kim GY, Kim MH, Lee KW, Kim MJ, Chaudhary M, et al. Nanocrystal Formulation to Enhance Oral Absorption of Silybin: Preparation, In Vitro Evaluations, and Pharmacokinetic Evaluations in Rats and Healthy Human Subjects. Pharmaceutics. 2024;16(8):1033. doi:10.3390/pharmaceutics16081033
BibTeX
@article{Seo2024,
author = {Seo, SeungRee and Kim, Gwan-Young and Kim, Min-Hwan and Lee, Kyung Won and Kim, Min-Jae and Chaudhary, Mansingh and Bikram, Khadka and Kim, Taeheon and Choi, Seungmok and Yang, Heejin and Park, Joo Won and Kim, Dae-Duk and Kim, Ki-Taek},
title = {Nanocrystal Formulation to Enhance Oral Absorption of Silybin: Preparation, In Vitro Evaluations, and Pharmacokinetic Evaluations in Rats and Healthy Human Subjects},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {8},
pages = {1033},
doi = {10.3390/pharmaceutics16081033}
}
EUVIMED